David Case, journalist for FastCompany.com, recently published news on a BPA research investigation. His article is one of the most startling yet on the politics involved with BPA safety and/or risk.
The National Toxicology Program, part of the National Institutes of Health, reports there is ‘some concern’ regarding the safety of BPA. The FDA has decided the ‘current levels of exposure’ of BPA is safe. David Case of FastCompany.com went on a research journey to discover the truth of BPA himself.
Case discovered just five companies make BPA in the U.S.; “Bayer, Dow, Hexion Specialty Chemicals, SABIC Innovative Plastics (formerly GE Plastics), and Sunoco. Together, they bring in more than $6 billion a year from the compound.” All of these corporations referred his questions of BPA safety to their trade association, the American Chemistry Council. The response from American Chemistry Council was weak and evasive. “Our view would be, Well, no, there isn’t anything to be concerned about,” says Steve Hentges, the council’s point person on BPA. “In a sense, you could have ‘some concern’ about just about anything.”
Case discovered that more than 100 independently funded experiments on BPA, about 90% have found evidence of adverse health effects at levels similar to typical human exposure. On the other hand, every industry funded study conducted, total of 14, has found no risk effects.
When you read Case’s article, you’ll have no doubts to the risks of BPA. The problem remains however, when is the FDA going to do something about it?
To read this VERY informative article, go to: http://www.fastcompany.com/magazine/132/the-real-story-on-bpa.html?page=0%2C0
